ENBIOTIX

enbiotix-logo

EnBiotix is a product-focused bioengineering company that advances front-line labeled products for chronic, recurrent, and life-threatening pulmonary infections. Through breakthrough systems and synthetic biology platforms, EnBiotix is transforming and revitalizing existing antibiotic classes to combat the global rise of drug-resistant bacterial infections. These approaches have developed a robust clinical product pipeline addressing a wide range of acute and chronic infections in what is today over a $40 billion market, with the potential to significantly impact the lives of patients, caregivers, and payors worldwide. It was founded in 2012 and is headquartered in Cambridge, Massachusetts.

#SimilarOrganizations #People #Financial #Website #More

ENBIOTIX

Social Links:

Industry:
Biotechnology Health Care Pharmaceutical

Founded:
2012-01-01

Address:
Cambridge, Massachusetts, United States

Country:
United States

Website Url:
http://www.enbiotix.com

Total Employee:
1+

Status:
Active

Contact:
5084001856

Email Addresses:
[email protected]

Total Funding:
17.61 M USD

Technology used in webpage:
SPF Domain Not Resolving Euro Microsoft Exchange Online Amazon Office 365 Mail Microsoft Azure DNS AJAX Libraries API GoDaddy DNS AWS Global Accelerator


Similar Organizations

aura-biosciences-logo

Aura Biosciences

Aura Biosciences is a biotechnology company that focuses on the development of drugs by using tumor targeted pseudovirions.

curex-allergy-logo

Curex Allergy

Curex offers at-home allergy testing, online doctor consultations and allergy treatment services.

generian-pharmaceuticals-logo

Generian Pharmaceuticals

Generian has developed an innovative approach to uncover first-in-class, gain-of-function drugs that activate key cellular networks.

labviva-logo

Labviva

Labviva is a digital marketplace for life science products that connects researchers with suppliers.

qsimulate-logo

QSimulate

QSimulate is leveraging the power of quantum mechanics to solve industrial-scale problems like never before.

resource-label-group-logo

Resource Label Group

Resource Label Group is a prime label and narrow web film converter with facilities.

salix-pharmaceuticals-logo

Salix Pharmaceuticals

Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.

united-allergy-services-logo

United Allergy Services

United Allergy Services knows that every patient is different. Each responds differently to different allergens. That’s why they

Current Employees Featured

jeffrey-d-wager_image

Jeffrey D. Wager
Jeffrey D. Wager Co-Founder, Chairman & CEO @ EnBiotix
Co-Founder, Chairman & CEO
2012-01-01

michael-garrett_image

Michael Garrett
Michael Garrett Chief Business Officer @ EnBiotix
Chief Business Officer

james-collins_image

James Collins
James Collins Founder @ EnBiotix
Founder

diane-joseph-mccarthy_image

Diane Joseph McCarthy
Diane Joseph McCarthy Senior Vice President, Discovery & Early Development @ EnBiotix
Senior Vice President, Discovery & Early Development
2019-01-01

Founder


james-collins_image

James Collins

jeffrey-d-wager_image

Jeffrey D. Wager

Acquisitions List

Date Company Article Price
2016-11-03 AMP Therapeutics - Antimicrobial Peptides AMP Therapeutics - Antimicrobial Peptides acquired by EnBiotix N/A

Investors List

vectura-group_image

Vectura Group

Vectura Group investment in Convertible Note - EnBiotix

sanford-biosciences_image

Sanford Biosciences

Sanford Biosciences investment in Convertible Note - EnBiotix

the-cystic-fibrosis-foundation_image

Cystic Fibrosis Foundation

Cystic Fibrosis Foundation investment in Convertible Note - EnBiotix

apeiron-holdings-limited-2_image

Apeiron Holdings Limited

Apeiron Holdings Limited investment in Series A - EnBiotix

wired-holdings_image

Wired Holdings

Wired Holdings investment in Series A - EnBiotix

Official Site Inspections

http://www.enbiotix.com Semrush global rank: 5.13 M Semrush visits lastest month: 729

  • Host name: a16e665f42988324c.awsglobalaccelerator.com
  • IP address: 76.223.105.230
  • Location: Seattle United States
  • Latitude: 47.54
  • Longitude: -122.3032
  • Metro Code: 819
  • Timezone: America/Los_Angeles
  • Postal: 98108

Loading ...

More informations about "EnBiotix"

EnBiotix - Crunchbase Company Profile & Funding

EnBiotix is a product-focused bioengineering company that advances front-line labeled products for chronic, recurrent, and life-threatening pulmonary …See details»

EnBiotix - Org Chart, Teams, Culture & Jobs | The Org

View EnBiotix's up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»

EnBiotix 2025 Company Profile: Valuation, Investors

Information on acquisition, funding, cap tables, investors, and executives for EnBiotix. Use the PitchBook Platform to explore the full profile.See details»

EnBiotix - VentureRadar

"EnBiotix is an engineered antibiotics company deploying novel systems and synthetic biology technologies developed by Prof. James J. Collins, the Termeer Professor of Medical …See details»

EnBiotix Inc - Company Profile and News - Bloomberg Markets

Company profile page for EnBiotix Inc including stock price, company news, executives, board members, and contact informationSee details»

EnBiotix - Biotech Careers

EnBiotix a is a product-focused bioengineering company commercializing anti-infective inventions of EnBiotix co-founder and SAB Chair Professor James J. Collins. These include engineered …See details»

enbiotix.com

Enbiotix.comSee details»

EnBiotix, Inc. - Drug pipelines, Patents, Clinical trials - Synapse

Explore EnBiotix, Inc. with its drug pipeline, therapeutic area, technology platform, 1 clinical trial, 14 news, and 2 literature, Disease Domain:Hemic and Lymphatic ...See details»

EnBiotix, Inc.:Company Profile & Technical Research,Competitor …

Discovery Company profile page for EnBiotix, Inc. including technical research,competitor monitor,market trends,company profile& stock symbolSee details»

EnBiotix's Leadership Team - Team members and org chart | The Org

The leadership team at EnBiotix has experience in business development, finance, and research.See details»

EnBiotix’s Competitors, Revenue, Number of Employees, Funding …

EnBiotix’s Profile, Revenue and Employees. EnBiotix is a Massachusetts-based biotechnology firm that develops and commercializes therapies for the treatment of chronic respiratory …See details»

EnBiotix, Inc. Overview | SignalHire Company Profile

EnBiotix, Inc. is a private company that has been in the industry for 11 years. The company currently specializes in the Pharmaceuticals, Biotechnology areas. The position of the …See details»

EnBiotix - Tech Company Profile - Gaebler.com Venture Capital …

EnBiotix is a product-focused bioengineering company commercializing anti-infective inventions of EnBiotix co-founder and SAB Chair Professor James J. Collins.See details»

Spexis acquires EnBiotix - 2021-09-01 - Crunchbase Acquisition …

Overview Acquired Organization: EnBiotix EnBiotix advances front-line labeled products for chronic, recurrent, and life-threatening pulmonary infections.See details»

Jeffrey Wager - Chairman & CEO at EnBiotix | The Org

Between 2011-2017, co-creator and BOD observer to Grupo Biotoscana SL, a Latin American specialty pharma roll-up financed by Advent International and Essex Woodlands Healthcare …See details»

EnBiotix CEO, Founder, Key Executive Team, Board of Directors

Explore {EnBiotix's key management people. Discover current leadership team members including founders, CEO, other executives and board directors.See details»

EnBiotix Closes $11 Million Financing Ahead of Merger with …

EnBiotix, a rare disease company currently focused on chronic respiratory disorders, said it closed an $11 million, pre-merger, convertible note financing led by Vectura Group, with participation …See details»

EnBiotix - Bill & Melinda Gates Foundation

To identify new treatments for enteric diseases by building a computational model of the genetic and molecular interactions between pathogenic gut microbes and the host, and analyzing the …See details»

enbiotix.com

Launching SoonSign up for our email list for updates, promotions, and more.See details»

Polyphor AG and EnBiotix Inc. Joint Meeting - Spexis

Forward-looking statement This presentation (the “Presentation”) has been prepared by Polyphor Ltd. (“the Company” and together with its subsidiary, “we”, “us” or the “Group”) solely for …See details»

linkstock.net © 2022. All rights reserved